Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125321271 | 12532127 | 1 | I | 20141117 | 20150225 | 20160706 | 20160706 | EXP | JP-ASTRAZENECA-2015SE20706 | ASTRAZENECA | 24863.00 | DY | M | Y | 62.30000 | KG | 20160706 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125321271 | 12532127 | 1 | PS | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Oral | 1327.5 | MG | 0 | 2.5 | MG | TABLET | QD | |||||
| 125321271 | 12532127 | 2 | SS | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | Oral | 1327.5 | MG | 0 | 5 | MG | TABLET | QD | |||||
| 125321271 | 12532127 | 3 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Oral | U | U | 0 | TABLET | ||||||||
| 125321271 | 12532127 | 4 | C | AVOLVE | DUTASTERIDE | 1 | Oral | 0 | CAPSULE | ||||||||||
| 125321271 | 12532127 | 5 | C | FLIVAS | NAFTOPIDIL | 1 | Oral | 0 | TABLET | ||||||||||
| 125321271 | 12532127 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | |||||||||||
| 125321271 | 12532127 | 7 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | Oral | 0 | TABLET | ||||||||||
| 125321271 | 12532127 | 8 | C | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125321271 | 12532127 | 1 | Type 2 diabetes mellitus |
| 125321271 | 12532127 | 2 | Type 2 diabetes mellitus |
| 125321271 | 12532127 | 3 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125321271 | 12532127 | DE |
| 125321271 | 12532127 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125321271 | 12532127 | Contusion | |
| 125321271 | 12532127 | Death | |
| 125321271 | 12532127 | Fall | |
| 125321271 | 12532127 | Gamma-glutamyltransferase increased | |
| 125321271 | 12532127 | Hepatic function abnormal | |
| 125321271 | 12532127 | Hypokinesia | |
| 125321271 | 12532127 | Renal impairment | |
| 125321271 | 12532127 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125321271 | 12532127 | 1 | 20140816 | 20151117 | 0 | |
| 125321271 | 12532127 | 2 | 20141118 | 20160120 | 0 |